24th May 2021 11:57
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | UDG HEALTHCARE PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 21 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
5,622,149 | 2.23% | 159,468 | 0.06% | ||
(2) | Derivatives (other than options): | ||||
103,344 | 0.04% | 4,872,691 | 1.93% | ||
(3) | Options and agreements to | ||||
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
TOTAL: | |||||
5,725,493 | 2.27% | 5,032,159 | 2.00% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 72 | 10.3200 GBP |
Purchase | 80 | 10.2600 GBP |
Purchase | 271 | 10.2200 GBP |
Purchase | 388 | 10.3239 GBP |
Purchase | 760 | 10.4589 GBP |
Purchase | 879 | 10.2924 GBP |
Purchase | 1,378 | 10.2400 GBP |
Purchase | 3,120 | 10.3908 GBP |
Purchase | 3,344 | 10.4075 GBP |
Purchase | 3,401 | 10.4438 GBP |
Purchase | 4,084 | 10.4193 GBP |
Purchase | 7,336 | 10.4240 GBP |
Purchase | 8,492 | 10.3677 GBP |
Purchase | 10,163 | 10.4594 GBP |
Purchase | 11,633 | 10.4242 GBP |
Purchase | 12,294 | 10.4239 GBP |
Purchase | 12,773 | 10.4215 GBP |
Purchase | 13,979 | 10.3504 GBP |
Purchase | 16,695 | 10.4200 GBP |
Purchase | 17,997 | 10.3471 GBP |
Purchase | 25,000 | 10.2500 GBP |
Purchase | 191,003 | 10.4094 GBP |
Purchase | 414,783 | 10.2300 GBP |
Purchase | 1,500,000 | 10.4383 GBP |
Sale | 281 | 10.2283 GBP |
Sale | 620 | 10.2305 GBP |
Sale | 630 | 10.4597 GBP |
Sale | 634 | 10.4397 GBP |
Sale | 1,059 | 10.3221 GBP |
Sale | 1,378 | 10.2400 GBP |
Sale | 1,378 | 10.2403 GBP |
Sale | 1,559 | 10.2350 GBP |
Sale | 2,011 | 10.4062 GBP |
Sale | 2,257 | 10.3142 GBP |
Sale | 5,061 | 10.2300 GBP |
Sale | 6,349 | 10.2323 GBP |
Sale | 6,396 | 10.3740 GBP |
Sale | 7,186 | 10.2320 GBP |
Sale | 8,678 | 10.2456 GBP |
Sale | 8,877 | 10.2500 GBP |
Sale | 8,980 | 10.2710 GBP |
Sale | 9,565 | 10.2910 GBP |
Sale | 10,629 | 10.4000 GBP |
Sale | 10,931 | 10.4600 GBP |
Sale | 11,609 | 10.4167 GBP |
Sale | 13,580 | 10.2982 GBP |
Sale | 14,419 | 10.2518 GBP |
Sale | 14,449 | 10.2377 GBP |
Sale | 18,360 | 10.2355 GBP |
Sale | 105,295 | 10.3751 GBP |
Sale | 113,715 | 10.3161 GBP |
Sale | 169,464 | 10.4237 GBP |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
|
|
| unit |
SWAP | Long | 8 | 10.4600 GBP |
CFD | Long | 281 | 10.2283 GBP |
SWAP | Long | 630 | 10.4597 GBP |
SWAP | Long | 634 | 10.4397 GBP |
SWAP | Long | 1,074 | 10.4599 GBP |
SWAP | Long | 2,011 | 10.4067 GBP |
CFD | Long | 5,706 | 10.2210 GBP |
CFD | Long | 6,396 | 10.3740 GBP |
SWAP | Long | 6,458 | 10.2770 GBP |
SWAP | Long | 10,535 | 10.4123 GBP |
SWAP | Long | 29,197 | 10.4260 GBP |
SWAP | Long | 40,754 | 10.4361 GBP |
SWAP | Long | 41,439 | 10.2938 GBP |
SWAP | Short | 11 | 10.4609 GBP |
CFD | Short | 3,120 | 10.3908 GBP |
SWAP | Short | 13,410 | 10.2436 GBP |
CFD | Short | 26,946 | 10.4608 GBP |
SWAP | Short | 36,505 | 10.4093 GBP |
SWAP | Short | 38,206 | 10.3277 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 24 May 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005387/en/
Copyright Business Wire 2021
Related Shares:
BarclaysUDG.L